|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.46 USD | +3.77% |
|
-3.17% | +11.36% |
| 07-20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 57.94 | 57.94 | 56.71 |
| Spread/Res. | -15.33% | -15.33% | -13.50% |
| Spread/Supp. | +3.54% | +3.54% | +22.61% |
| Support | 47.38 | 47.38 | 40.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
Select your edition
All financial news and data tailored to specific country editions
